Nuzenio

Biopharma Dive Biopharma

Biopharma Dive Biopharma entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 21 latest news signals 1 publisher sources 100/100 entity strength

Latest news

‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culprit - BioPharma DiveBioPharma Dive · Fri, 07 Aug 2026 15:02:34 GMT Latigo IPO raises nearly $350M for pain drug development - BioPharma DiveBioPharma Dive · Fri, 07 Aug 2026 13:05:46 GMT Replimune rebounds to win FDA approval of melanoma drug - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 21:16:19 GMT Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 19:14:51 GMT Takeda approval ushers in new wave of sleep drugs - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 16:10:45 GMT With $263M, LifeMine unearths a new drug for organ transplants - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 13:40:35 GMT FDA approves Moderna’s mRNA flu vaccine - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 11:10:45 GMT Cardiac drug developer Braveheart banks more than $382M in IPO - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 03:18:37 GMT

Timeline

Fri, 07 Aug 2026 15:02:34 GMT‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culprit - BioPharma Dive

Fri, 07 Aug 2026 13:05:46 GMTLatigo IPO raises nearly $350M for pain drug development - BioPharma Dive

Thu, 06 Aug 2026 21:16:19 GMTReplimune rebounds to win FDA approval of melanoma drug - BioPharma Dive

Thu, 06 Aug 2026 19:14:51 GMTAlkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M - BioPharma Dive

Thu, 06 Aug 2026 16:10:45 GMTTakeda approval ushers in new wave of sleep drugs - BioPharma Dive

Thu, 06 Aug 2026 13:40:35 GMTWith $263M, LifeMine unearths a new drug for organ transplants - BioPharma Dive

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Dive19 live mentions FDA7 live mentions IPO4 live mentions BioPharma Dive3 live mentions Pfizer3 live mentions Significant2 live mentions Revolution2 live mentions Intellia2 live mentions Replimune2 live mentions BioPharma Dive Replimune2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Biopharma Dive Biopharma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.